Immune checkpoint inhibitors and elderly people: A review-Reference-Cited by-同舟云学术

Immune checkpoint inhibitors and elderly people: A review

Published:2017-09 Issue: Volume:82 Page:155-166
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Daste Amaury^ORCID,Domblides Charlotte,Gross-goupil Marine,Chakiba Camille,Quivy Amandine,Cochin Valérie,de Mones Erwan,Larmonier Nicolas,Soubeyran Pierre,Ravaud Alain

Funder

Pfizer

Novartis

MSD

Roche

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference101 articles.

1. Cancer statistics, 2016;Siegel;CA Cancer,2016

2. Cancer in older persons: an international issue in an ageing world;Yancik;Semin Oncol,2004

3. Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration;Talarico;J Clin Oncol,2004

4. Enrollment of older patients in cancer treatment trials in Canada: why is age a barrier?;Yee;J Clin Oncol,2003

5. Targeted therapy and elderly people: a review;Daste;Eur J Cancer,2016

Cited by 153 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inclusion, characteristics, and reporting of older adults in FDA registration studies of immunotherapy, 2018–2022;Journal for ImmunoTherapy of Cancer;2024-08

2. Kopf-Hals-Onkologie des älteren Patienten;Die MKG-Chirurgie;2024-07-30

3. Toxicity in Older Patients with Cancer Receiving Immunotherapy: An Observational Study;Drugs & Aging;2024-05

4. Clinical features and treatment outcomes of PD-1 inhibitor therapy in elderly patients (≥ 65 years) with advanced esophageal squamous cell carcinoma: a real-world study;Clinical and Translational Oncology;2024-04-11

5. A specific enterotype derived from gut microbiome of older individuals enables favorable responses to immune checkpoint blockade therapy;Cell Host & Microbe;2024-04